Scholarlink

Background <p>Cervical cancer represents a major global health problem, ranking as the fourth most prevalent cancer among women across the globe. The primary risk factor associated with cervical intraepithelial neoplasia and cervical cancer is the human papillomavirus (HPV). Curcumin (Cur), extracted from the root of the Curcuma longa plant, is an anticancer, chemoprotective, and gene/protein regulating agent, which refers to its ability to exert beneficial effects in various aspects of cancer prevention and treatment.</p> Objectives <p>This study investigated the tumor inhibitory effect (anti-tumoral effect) of a novel curcumin nanoemulsion (Cur-NE) on HPV<sup>+</sup> TC-1 cells in vitro and in vivo.</p> Methods <p>The MTT assay was used to evaluate the cytotoxicity of Cur-NE and Cur on TC-1 cancer cells and MC3T3 normal cells. In vitro assessment was performed using flow cytometry (Annexin/PI) to examine apoptosis and quantitative PCR (qPCR) analysis to determine the gene expression levels of <i>E6</i> and <i>E7</i> human papillomavirus oncogenes, as well as their associated protein factors, <i>p53</i> and <i>Rb</i>. In addition, C57BL/6 female mice burdening HPV + TC-1 tumor as cervical cancer models were used to investigate the tumor inhibitory effect of the Cur-NE in vivo compared to free curcumin.</p> Results <p><i>In vitro</i> anti-tumoral studies showed that apoptosis and inhibiting cellular proliferation in TC-1 cells were induced effectively by curcumin nanoemulsion. Accordingly, curcumin nanoemulsion reduced mRNA expression levels of <i>E6</i> and <i>E7</i> HPV oncogenes and increased <i>p53</i> and <i>Rb</i> levels in a concentration lower than free curcumin (<i>P</i> &lt; 0.05). Furthermore, the suppression and inhibition of subcutaneous TC-1 tumor growth were more pronounced with the curcumin nanoemulsion compared to free curcumin (<i>P</i> &lt; 0.01).</p> Conclusion <p>These preeminent preclinical results indicate the potential of this curcumin nanoformulation as an efficient treatment approach for cervical cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Curcumin nanoemulsion suppresses HPV oncogenes and inhibits cervical cancer progression: in vitro and in vivo study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月27日

查看全文
  • Mehrnaz Karimi,
  • Masoud Parsania,
  • Negar Motakef Kazemi,
  • Mahnaz Qomi,
  • Mahsa Hadipour Jahromy

摘要

Background

Cervical cancer represents a major global health problem, ranking as the fourth most prevalent cancer among women across the globe. The primary risk factor associated with cervical intraepithelial neoplasia and cervical cancer is the human papillomavirus (HPV). Curcumin (Cur), extracted from the root of the Curcuma longa plant, is an anticancer, chemoprotective, and gene/protein regulating agent, which refers to its ability to exert beneficial effects in various aspects of cancer prevention and treatment.

Objectives

This study investigated the tumor inhibitory effect (anti-tumoral effect) of a novel curcumin nanoemulsion (Cur-NE) on HPV+ TC-1 cells in vitro and in vivo.

Methods

The MTT assay was used to evaluate the cytotoxicity of Cur-NE and Cur on TC-1 cancer cells and MC3T3 normal cells. In vitro assessment was performed using flow cytometry (Annexin/PI) to examine apoptosis and quantitative PCR (qPCR) analysis to determine the gene expression levels of E6 and E7 human papillomavirus oncogenes, as well as their associated protein factors, p53 and Rb. In addition, C57BL/6 female mice burdening HPV + TC-1 tumor as cervical cancer models were used to investigate the tumor inhibitory effect of the Cur-NE in vivo compared to free curcumin.

Results

In vitro anti-tumoral studies showed that apoptosis and inhibiting cellular proliferation in TC-1 cells were induced effectively by curcumin nanoemulsion. Accordingly, curcumin nanoemulsion reduced mRNA expression levels of E6 and E7 HPV oncogenes and increased p53 and Rb levels in a concentration lower than free curcumin (P < 0.05). Furthermore, the suppression and inhibition of subcutaneous TC-1 tumor growth were more pronounced with the curcumin nanoemulsion compared to free curcumin (P < 0.01).

Conclusion

These preeminent preclinical results indicate the potential of this curcumin nanoformulation as an efficient treatment approach for cervical cancer.